Clinical Trials Browser

Phase 2 × INDUSTRY × Suramin × Clear all

NCT01038752 2015-05-21

Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer

Phase 2 Terminated

14 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms